Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniel Mendoza-Posada"'
Publikováno v:
Lung India, Vol 29, Iss 4, Pp 325-328 (2012)
Background : Mexico′s National Institute of Respiratory Diseases (NIRD) is a third-level national reference center. Primary adenoid cystic carcinoma (PACC) is an uncommon neoplastic disorder; hence improvements in the description of this disease ar
Externí odkaz:
https://doaj.org/article/18b613c2673c45b6aa8d06df4b5f95db
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 37, Iss 2, Pp 277-280 (2011)
Externí odkaz:
https://doaj.org/article/d2c0174d37d24fdca9c7d1d2d93c9719
Autor:
null Rufino Echegoyen-Carmona, null Daniel Mendoza-Posada, null Catalina Camacho-Mendoza, null Oswaldo Rafael Sánchez-Campos
Publikováno v:
Journal of Analytical Oncology. 1:62-66
Retrospective analysis of 101 lung cancer patients treated at the INER [National Respiratory Diseases Institute] in Mexico from January 2006 to October 2007. Objective: Analysis of clinical situation and treatment. Results: The study comprised 59 men
Publikováno v:
Lung India : Official Organ of Indian Chest Society
Lung India, Vol 29, Iss 4, Pp 325-328 (2012)
Lung India, Vol 29, Iss 4, Pp 325-328 (2012)
Background : Mexico's National Institute of Respiratory Diseases (NIRD) is a third-level national reference center. Primary adenoid cystic carcinoma (PACC) is an uncommon neoplastic disorder; hence improvements in the description of this disease are
Autor:
Claudia Arce, Teresa Vela-Chavez, Carlos Gamboa-Vignole, Nestor Villafañe, Enrique Bargallo-Rocha, Daniel Mendoza-Posada
Publikováno v:
BMC Cancer
Autor:
Oscar Arrieta, Patricia Castillo, Enrique Guzman, Jaime de la Garza, Alma Astorga, Luis Martinez, Daniel Mendoza-Posada, David Saavedra-Perez, Roberto Kuri, Alejandro Avilés-Salas
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 119 (2009)
BMC Cancer
BMC Cancer
Background Central nervous system is a common site of metastasis in NSCLC and confers worse prognosis and quality of life. The aim of this prospective study was to evaluate the prognostic significance of clinical-pathological factors (CPF), serum CEA
Autor:
Arrieta, Oscar1 ogar@servidor.unam.mx, Saavedra-Perez, David1 seelowen@msn.com, Kuri, Roberto1 cuitlacoche74@hotmail.com, Aviles-Salas, Alejandro2 alejandroaviles2001@yahoo.com, Martinez, Luis3 luismartinbarr@yahoo.com.mx, Mendoza-Posada, Daniel3 danielm3742@gmail.com, Castillo, Patricia3 patycastillog@hotmail.com, Astorga, Alma1 alma_astorga@yahoo.es, Guzman, Enrique3 enriqueg@prodigy.net.mx, De la Garza, Jaime4 jdelagarza1@prodigy.net.mx
Publikováno v:
BMC Cancer. 2009, Vol. 9, Special section p1-9. 9p. 3 Charts, 1 Graph.
Autor:
Mendoza-Posada, Daniel1, Vela-Chavez, Teresa2, Bargallo-Rocha, Enrique3, Villafañe, Nestor4, Gamboa-Vignole, Carlos5, Arce, Claudia1 haydeearce@hotmail.com
Publikováno v:
BMC Cancer. 2007 Supplement 1, Vol. 7, pA1-1. 1p.